Table 1 Demographic characteristics of all patients (values are presented as number (%) or median [IQR])
|  | Placebo (n = 80) | Dexa (n = 80) | P |
|---|---|---|---|
Male (%) | 32 (40.0) | 30 (37.5) | 0.871 |
Age, years | 85.0 [79.8, 90.2] | 84.5 [79.0, 89.0] | 0.514 |
BMI | 20.3 [19.2, 21.5] | 20.1 [19.3, 20.8] | 0.342 |
ASA ≥ 3 (%) | 66 (82.5) | 68 (85.0) | 0.83 |
Pain degree at admission (%) | Â | Â | 0.45 |
 Mild | 6 (7.5) | 4 (5.0) |  |
 Moderate | 60 (75.0) | 56 (70.0) |  |
 Severe | 14 (17.5) | 20 (25.0) |  |
Comorbidities | |||
Hypertension (%) | 61 (76.2) | 58 (72.5) | 0.717 |
CAP or COPD (%) | 38 (47.5) | 33 (41.2) | 0.524 |
 COPD (%) | 13 (16.3) | 8 (10.0) | 0.242 |
Diabetes (%) | 26 (32.5) | 22 (27.5) | 0.605 |
CHF or CHD (%) | 31 (38.8) | 27 (33.8) | 0.622 |
Antiplatelet therapy (%) | 18 (22.5) | 17 (21.2) | 1 |
Malignant tumor (%) | 4 (5.0) | 4 (5.0) | 1 |
Chronic kidney disease (%) | 10 (12.5) | 9 (11.2) | 1 |
Pre-injury mobility and status | |||
ADL | Â | Â | 0.09 |
 21–40 | 21 (26.3) | 10 (12.5) |  |
 41–59 | 28 (35.0) | 33 (41.3) |  |
 61–100 | 31 (38.7) | 37 (46.2) |  |
MNA | 10.0 [8.0, 11.2] | 10.0 [8.8, 11.0] | 0.591 |
MMSE | 16.0 [14.0, 23.0] | 17.5 [12.8, 22.2] | 0.678 |
Cognitive disorder (%) | Â | Â | 0.21 |
 Moderate | 53 (66.2) | 48 (60.0) |  |
 Mild | 15 (18.8) | 24 (30.0) |  |
 No | 12 (15.0) | 8 (10.0) |  |
Pre-injury living condition (%) | Â | Â | 0.296 |
 Independently at home | 15 (18.8) | 10 (12.5) |  |
 At home with help needed | 45 (56.2) | 42 (52.5) |  |
 Aged care facility | 20 (25.0) | 28 (35.0) |  |